ID

45990

Description

Principal Investigator: Stephen S. Rich, PhD, University of Virginia, Charlottesville, VA, USA MeSH: Diabetes Mellitus, Type 1,Autoimmune Diseases,Autoantibodies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000910 Type 1 Diabetes Genetics Consortium (T1DGC) was formed to address issues of limited sample size and consistency of phenotyping that had limited genetic investigations on risk of type 1 diabetes (T1D). The T1DGC first collected affected sib pair (ASP) families from four geographic networks (Asia-Pacific, Europe, North America, United Kingdom). In addition, T1D parent-offspring trios as well as cases and controls were ascertained from existing and de novo collections. For T1D, the genome-wide association study (GWAS) design has been successful at detecting ~50 loci that contribute disease risk. However, in the case of T1D as well as almost all other traits, the sum of these loci does not fully explain the heritability estimated from familial studies. One possibility for the undiscovered contribution to familial aggregation is that additional variants exist but have not yet been found because they have not effectively been targeted by the GWAS design. In this study, we focus on a specific class of large deletions/duplications -- copy number variants (CNVs) - and particularly to the subset of these loci that mutate rapidly, are not tagged by SNPs, and are highly polymorphic. The T1DGC assembled 2,601 T1D ASP families and 69 Parent-T1D offspring trios, that were eligible for this study. All samples included in this series have reported or self-declared European ancestry. All DNA samples were collected after approval from relevant institutional research ethics committees. Importantly, the source of DNA for CNV evaluation was uniform within a family (either all from PBMC or from EBV-transformed cell lines). We use a family based design that was optimized to capture these previously untested variants. We then perform a genome-wide scan to assess their contribution to T1D.

Link

dbGaP study=phs000910

Keywords

  1. 4/11/24 4/11/24 - Madita Rudolph
Copyright Holder

Stephen S. Rich, PhD, University of Virginia, Charlottesville, VA, USA

Uploaded on

April 11, 2024

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

dbGaP phs000910 Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV) Study

Eligibility Criteria

Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
To be included in the study, an affected sibpair (ASP) family had to have at least one ASP available for sampling; availability of one or both biological parents; and the same source (blood or cell line) of DNA for all family members. For parent-offspring trio families, all three members (both paretns and the T1D-affected offspring was required to have the same source of DNA (blood or cell line). An individual was designated as affected with type 1 diabetes (T1D) if he or she had documented T1D with onset at <35 years of age, had used insulin within 6 months of diagnosis, and had no concomitant disease or disorder associated with diabetes. Preference was given to those families having participants with ImmnoChip genotyping.
Description

Elig.phs000910.v1.p1.1

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
UMLS CUI [2,1]
C0011854
UMLS CUI [3,1]
C0470187
UMLS CUI [3,2]
C0030551
UMLS CUI [3,3]
C0870078

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000910.v1.p1.1
Item
To be included in the study, an affected sibpair (ASP) family had to have at least one ASP available for sampling; availability of one or both biological parents; and the same source (blood or cell line) of DNA for all family members. For parent-offspring trio families, all three members (both paretns and the T1D-affected offspring was required to have the same source of DNA (blood or cell line). An individual was designated as affected with type 1 diabetes (T1D) if he or she had documented T1D with onset at <35 years of age, had used insulin within 6 months of diagnosis, and had no concomitant disease or disorder associated with diabetes. Preference was given to those families having participants with ImmnoChip genotyping.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0011854 (UMLS CUI [2,1])
C0470187 (UMLS CUI [3,1])
C0030551 (UMLS CUI [3,2])
C0870078 (UMLS CUI [3,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial